RLS Afflicts One in Three CKD Patients
STOCKHOLM—More than one third of patients with stage III-IV CKD have restless legs syndrome (RLS), an Italian study found.
STOCKHOLM—More than one third of patients with stage III-IV CKD have restless legs syndrome (RLS), an Italian study found.
GRAPEVINE, Tex.—Higher levels of 25-hydroxyvitamin D (25 (OH) D) may lower the risk of anemia and elevated C-reactive protein levels may raise the risk, according to new study findings that may explain much of the high prevalence of anemia among individuals with kidney disease, researchers conclude.
AMAG Pharmaceuticals, Inc., of Cambridge, Mass., has announced that the FDA has accepted for standard review its New Drug Application (NDA) for ferumoxytol as an IV treatment of iron deficiency anemia in CKD patients.
Universal access to health care might help to overcome racial and ethnic barriers to treatment for kidney disease, according to two studies.
The prevalence of CKD among adults in Beijing, China is 13%, according to a recent study published in the American Journal of Kidney Diseases (2008;51:373-384).
Unable to excrete excess potassium, most dialysis patients must adjust their intake.
GRAPEVINE, Tex.—Patients with the metabolic syndrome and decreased estimated glomerular filtration rate (eGFR) are at increased risk of having peripheral arterial disease (PAD), a study shows.
Adequate calorie intake, combined with a protein-restricted diet, can slow CKD progression.
Researchers who studied a large cohort of Chinese men found an inverse relationship between alcohol consumption and end-stage renal disease (ESRD).
Serum uric acid levels in the high-normal range are associated with reduced renal function in patients with type 1 diabetes, according to researchers.